An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies.
Saved in:
| Title: | An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies. |
|---|---|
| Authors: | Findlay A; Pharmaxis, Frenchs Forest, New South Wales, Australia., Turner C; Pharmaxis, Frenchs Forest, New South Wales, Australia., Schilter H; Pharmaxis, Frenchs Forest, New South Wales, Australia., Deodhar M; Pharmaxis, Frenchs Forest, New South Wales, Australia., Zhou W; Pharmaxis, Frenchs Forest, New South Wales, Australia., Perryman L; Pharmaxis, Frenchs Forest, New South Wales, Australia., Foot J; Pharmaxis, Frenchs Forest, New South Wales, Australia., Zahoor A; Pharmaxis, Frenchs Forest, New South Wales, Australia., Yao Y; Pharmaxis, Frenchs Forest, New South Wales, Australia., Hamilton R; Pharmaxis, Frenchs Forest, New South Wales, Australia., Brock M; Quanterix, Billerica, Massachusetts, USA., Raso C; Quanterix, Billerica, Massachusetts, USA., Stolp J; Pharmaxis, Frenchs Forest, New South Wales, Australia., Galati M; Pharmaxis, Frenchs Forest, New South Wales, Australia., Hamprecht D; Pharmaxis, Frenchs Forest, New South Wales, Australia., Charlton B; Pharmaxis, Frenchs Forest, New South Wales, Australia., Jarolimek W; Pharmaxis, Frenchs Forest, New South Wales, Australia. |
| Source: | Clinical and translational medicine [Clin Transl Med] 2021 Nov; Vol. 11 (11), pp. e572. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326 (Electronic) Linking ISSN: 20011326 NLM ISO Abbreviation: Clin Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2001-1326 |
|---|---|
| DOI: | 10.1002/ctm2.572 |
